Onkologinėmis ligomis sergančiųjų žmonių asociacija "Švęsk gyvenimą" - financials and debts
Company age: 3 y. 5 mo.
Company finances
|
EUR
|
2023
From: 2023-04-21
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|
|
Financial data
|
|||
| Sales revenue | 1,421 | 1,668 | 2,660 |
| Profit before tax | 1,296 | 670 | 0 |
| Net profit | 1,296 | 670 | 0 |
| Equity | 0 | 0 | 0 |
| Liabilities | 0 | 0 | 0 |
| Non-current assets | - | - | - |
| Current assets | - | - | - |
| Total assets | 0 | 0 | 0 |
|
Financial indicators
|
|||
| Revenue change y/y | - | +17.4% | +59.5% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | - | - | - |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | - | - | - |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 91.2% | 40.2% | 0.0% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 91.2% | 40.2% | 0.0% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | - | - |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | - | - | - |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Social security debts
The company had no debts to Sodra
VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Onkologinemis ligomis serganciuju žmoniu asociacija "Švesk gyvenima" (code 306303053) is an Association engaged in activities of other membership organisations n.e.c. In 2025, it generated revenue of €2.7K, up 59.5% year on year and 87.2% over two years, indicating a clear upward revenue trajectory. The organisation’s 2024 revenue was €1.7K, compared with €1.4K in 2023, showing steady growth before the stronger increase in 2025. Profitability weakened in the earlier years of the series: net profit was €1.3K in 2023 and €670 in 2024, with profit margin declining from 91.2% to 40.2%. No net profit figure is provided for 2025, so the latest year can be assessed mainly through revenue growth. The financial profile remains very small in absolute terms, but the recent revenue expansion suggests improving activity levels. No balance sheet or staff data is provided, so asset, leverage and productivity ratios cannot be assessed from the available figures.